Proteins and Peptides

13 Feb 2007 QSV Biologics, Ltd., and Critical Biologics Corp., Sign Contract for cGMP Manufacture of Gelsolin for Critical Care Applications
09 Feb 2007 Zelos Therapeutics' Ostabolin-CTM Increases Bone Mineral Density in Phase 2 Osteoporosis Trial
09 Feb 2007 EU-Approval for Continuous Infusion of KOGENATE(R) Bayer
09 Feb 2007 LAB International Completes Patient Enrollment in Its Growth Hormone Releasing Hormone (GHRH) Product Phase IIA Trial
09 Feb 2007 Amarillo Biosciences Announces Open Enrollment in Its Phase 2 Study of Orally Administered Interferon Alpha in the Treatment of Oral Warts in HIV-Positive Patients
09 Feb 2007 Presentations at Stroke Conference Update Development of Viprinex(TM) (ancrod)
07 Feb 2007 Jerini expands collaboration with Baxter to develop non-intraveneous hemophilia therapy
07 Feb 2007 Gloucester Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial in Patients with Multiple Myeloma
06 Feb 2007 Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
06 Feb 2007 Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies
03 Feb 2007 Adnexus Therapeutics Announces Presentation Of Interim Phase I Results For CT-322, First Adnectin Therapeutic In Humans
02 Feb 2007 Overview On 2006 Sales Of TOP 20 Biologics To Be Released On February 26
02 Feb 2007 Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline
02 Feb 2007 Grifols announces FDA approval of Alphanate(R) to treat von Willebrand disease
02 Feb 2007 Successful Oral Insulin Toxicity Result - Oradel(TM), Loaded With Generic Insulin
31 Jan 2007 Gloucester Pharmaceuticals Receives Special Protocol Assessment for Pivotal Phase II Trial of Romidepsin in Patients with Peripheral T-Cell Lymphoma
31 Jan 2007 OctoPlus initiates Locteron Phase II clinical study in chronic hepatitis C
31 Jan 2007 ZymoGenetics Begins Clinical Trial for PEG-Interferon lambda as Potential Treatment for Viral Infection
31 Jan 2007 Alfacell Corporation Granted U.S. Orphan Drug Designation for ONCONASE(R) for Treatment of Malignant Mesothelioma
30 Jan 2007 ReceptoPharm Begins Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy
27 Jan 2007 Largest-ever stroke registry confirms safety of Actilyse(R) thrombolysis treatment for acute ischaemic stroke
26 Jan 2007 Bayer discontinues Trasylol(R) clinical trial program in non-CABG indications
26 Jan 2007 Spectrum Pharmaceuticals Initiates Phase 2b Trial for Ozarelix in Patients with Benign Prostate Hypertrophy
26 Jan 2007 Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch
26 Jan 2007 BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS®1 to Treat Distal Radius Fractures

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up